References
- Jones-Caballero M, Penas PF, Garcia-Diez A, Badia X, Chren MM. The Spanish version of Skindex-29. Cultural adaptation and preliminary evidence of validity and equivalence with the original American version. Int J Dermatol 2000; 39:907-912 https://doi.org/10.1046/j.1365-4362.2000.00944.x
- Abeni D, Picardi A, Pasquini P, Melchi CF, Chren MM. Further evidence of the validity and reliability of the Skindex-29: An Italian study on 2,242 dermatological outpatients. Dermatology 2002; 204:43-49 https://doi.org/10.1159/000051809
- Schmidt S, Fischer TW, Chren MM, Strauss BM, Elsner P. Strategies of coping and quality of life in women with alopecia. Br J Dermatol 2001;144:1038-1043 https://doi.org/10.1046/j.1365-2133.2001.04195.x
- Wolkenstein P, Zeller J, Revuz J, Ecosse E, Leplege A. Quality of life impairment in neurofibromatosis type 1. Arch Dermatol 2001;137:1421-1430
- Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993;46:1417-1432 https://doi.org/10.1016/0895-4356(93)90142-N
- Finlay AY. Quality of life assessments in dermatology. Semin Cutan Med Surg 1998;17:291-296 https://doi.org/10.1016/S1085-5629(98)80026-6
- Mckenna KE, Stem RS. The outcomes movement and new measures of the severity of psoriasis. J Am Acad Dermatol 1996 ;34:534-538 https://doi.org/10.1016/S0190-9622(96)90469-7
- Finlay AY. The outcomes movement and new measures of psoriasis. J Am Acad Dermatol 1997 ;36:502-503
- Jemec GB, Wulf HC. Patient-physician consensus on quality of life in dermatology. Clin Exp Dermatol 1996;21:177-179 https://doi.org/10.1111/j.1365-2230.1996.tb00057.x
- Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996 ;107:707-713 https://doi.org/10.1111/1523-1747.ep12365600
- Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997 ;133:1433-1440 https://doi.org/10.1001/archderm.133.11.1433
- Hunt SM, Alonso J, Bucquet D, Niero M, Wiklund I, McKenna S. Cross-cultural adaptation of health measures. European Group for Health Management and Quality of Life Assessment. Health Policy. 1991 ;19:33-44 https://doi.org/10.1016/0168-8510(91)90072-6
- Shuster S, Fisher G, Harris E, Binnell D. The effects of skin disease on self-image. Br J Dermatol 1978; 99:18-19
- Jowett S & Ryan T. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 1985; 20: 425-429 https://doi.org/10.1016/0277-9536(85)90021-8
- Rubinow DR, Peck GL, Squillace KM, Gantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987;17:25-32 https://doi.org/10.1016/S0190-9622(87)70166-2
- Wu SF, Kinder BN, Trunnell TN, Fulton JE. Role of anxiety and anger in acne patients: a relationship with the severity of the disorder. J Am Acad Dermatol. 1988;18:325-333 https://doi.org/10.1016/S0190-9622(88)70047-X
- Lucas CJ. Personality of students with acne vulgaris. BMJ 1961;2:354 https://doi.org/10.1136/bmj.2.5248.354
- Wittkower E. Acne vulgaris: a psychosomatic study. Br J Dermatol 1951;63:214-223 https://doi.org/10.1111/j.1365-2133.1951.tb13715.x
- Krowchuk DP, Stancin T, Keskinen R, Walker R, Bass J, Anglin TM. The psychosocial effects of acne on adolescents. Pediatr Dermatol 1991;8:332-338 https://doi.org/10.1111/j.1525-1470.1991.tb00945.x
- Myhill JE, Leichttnan SR, Burnett JW. Self-esteem and social assertiveness in patients receiving isotretinoin treatment for cystic acne. Cutis 1988;41:171-173
- Schachter RJ, Pantel ES, Glassman GM, Zweibelson I. Acne vulgaris and psychologic impact on high school students. N Y State J Med 1971;71:2886-2890
- Van der Meeren HLM, van der Schaar WW, van den Hurk CMAM. The psychological impact of severe acne. Cutis. 1985;36:84-86